---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-24-000246"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:11:35.240496+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q2 revenue $315.6M (+52% YoY), turns profitable; raises FY outlook

## Summary
- Revenue $315.6M, up 52% YoY; subscribers 1.9M (+43% YoY).
- Net income $13.3M vs net loss $7.2M YoY; adjusted EBITDA $39.3M (+270% YoY).
- Raises FY2024 revenue guidance to $1.37-$1.40B; adjusted EBITDA guidance $140-$155M.
- Announced up to $100M share repurchase program over three years.

## SEC filing metadata
- accession: 0001773751-24-000246
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000246/0001773751-24-000246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000246/hims-20240805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-24-000246
- JSON: https://secwatch.observer/filing/0001773751-24-000246.json
- Plain text: https://secwatch.observer/filing/0001773751-24-000246.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.